Autologous Hematopoietic Stem Cell Transplantation (AHSCT): Standard of Care for Relapsing–Remitting Multiple Sclerosis Patients

Autologous hematopoietic stem cell transplantation (AHSCT) has been used in the treatment of highly active multiple sclerosis (MS) for over two decades. It has been demonstrated to be highly efficacious in relapsing–remitting (RR) MS patients failing to respond to disease-modifying drugs (DMDs). AHS...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertolotto, Antonio, Martire, Serena, Mirabile, Luca, Capobianco, Marco, De Gobbi, Marco, Cilloni, Daniela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606396/
https://www.ncbi.nlm.nih.gov/pubmed/32548740
http://dx.doi.org/10.1007/s40120-020-00200-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606396/
https://www.ncbi.nlm.nih.gov/pubmed/32548740
http://dx.doi.org/10.1007/s40120-020-00200-9

Ejemplares similares